Fortrea Holdings disputes inaccurate reports of trial conduct made by ACELYRIN, INC regarding two clinical trials on its investigational product, stating that their study conduct was in accordance with protocol and regulatory requirements.
AI Assistant
FORTREA HOLDINGS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.